investor relations
Technology meets medicine
DATATRAK is devoted to providing exceptional services to our investors.
Consider the following:
- DATATRAK is a Company that will benefit from the continued advancement of technology and Internet usage within the pharmaceutical industry. Further strides away from paper and towards complete technology use in clinical trials are inevitable.
- The eventual market size for the complete eClinical spectrum is projected to exceed several billion dollars annually.
- Because of the conservative nature of the pharmaceutical industry, a successful track record with experience in servicing international clinical trials with technology is an extremely important criterion for a vendor in this field. We continue to prove our value in this arena.
- It is advantageous to the FDA to receive data in electronic format because it speeds up FDA review of new drugs.
- DATATRAK pioneered a transactional-based pricing model, which allows for renewable revenue streams with each clinical trial instead of underselling its value too early by using global license deals.
2008 Investor Presentation
2008 Investor Presentation Slides
DATATRAK Corporate Governance
Audit Committee Charter
Code of Business Conduct and Ethics
Financial Code of Ethics
Compensation Committee Charter
Nominating and Corporate Governance Committee Charter
Policy Regarding the Granting of Equity Based Compensation Awards
DATATRAK Financials
All of DATATRAK's filings can be found at the United States Securities and Exchange (SEC) website, www.sec.gov.
The following links will open a new browser window and take you directly to the selected DATATRAK SEC filings page on the SEC web site.
DATATRAK Form 10-K Reports
DATATRAK Form 10-Q Reports
DATATRAK Section 16 Reports
DATATRAK Form 8-K Reports
|
